[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]
Browsing Category
Life Sciences
Pendulum Therapeutics Releases In-Depth Profile of Akkermansia Muciniphila, a Key Strain Forging a…
New publication reveals how a keystone strain exerts potential to impact a spectrum of health outcomes through immune and metabolic regulation…
Iveric Bio Announces Presentation of Post-Hoc Analysis at Macula Society from GATHER1 Clinical Trial…
IVERIC bio, Inc. announced a post-hoc analysis from the Zimura (avacincaptad pegol) GATHER1 clinical trial which explored enhanced Optical Coherence…
Relation Therapeutics, the Active-Graph Machine Learning Drug Discovery Company, Names David Roblin…
DCVC and Magnetic Ventures co-led a $25 million seed financing, with participation from Khosla Ventures, OMERS Ventures, and firstminute Capital,…
Charm Therapeutics Launches With A $50 Million Series A Financing To Transform Structure-based Drug…
CHARM Therapeutics (“CHARM”, “The Company”), a 3D deep-learning research company discovering and developing transformational medicines founded by…
icometrix Announces DocPanel to Introduce icobrain Portfolio
icometrix announced that DocPanel has selected the icobrain portfolio to strengthen its AI imaging capability and transform the market for people with…
Degron Therapeutics Raises $22 Million Series A Financing to Accelerate Growth and Expand…
Degron Therapeutics ("Degron"), a biotechnology company developing a new class of small-molecule medicines that target previously undruggable targets,…
Trinity Life Sciences Launches TGaS Advisors’ Government Pricing Services
Sixty-Three Percent of Emerging Life Sciences Companies Outsource Government Pricing Capabilities to a Third-Party Vendor Rather than Implement a…
Element Biosciences Announces First Customer Shipments and New Offerings for AVITI System
Element Biosciences, Inc., developer of the Element AVITI System, a new and disruptive DNA sequencing platform, announced it has shipped multiple…
Better Therapeutics Announces Issuance of U.S. Patent Covering Key Features of Their Prescription…
Better Therapeutics, Inc., a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the…
Standigm Signs MOU with Merck Korea for AI drug Discovery Research
Standigm Inc., the leading workflow artificial intelligence (AI) drug discovery company, announced the signing of a Memorandum of Understanding (MOU)…